Storskalig produktion av Cardiomyocytes från Human pluripotenta stamceller med hjälp av en mycket reproducerbar liten molekyl baserad differentiering protokoll
Here, we present a robust, fast and scalable cardiomyocyte differentiation protocol for human pluripotent stem cells (hPSCs). Cardiomyocytes derived using this large-scale method can provide sufficient cell numbers for their effective use in human cardiovascular disease modeling, high-throughput drug screening, and potentially clinical applications.